Product Description
This digital document is an article from Science News, published by Science Service, Inc. on June 6, 2009. The length of the article is 553 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Genetic study links narcolepsy to autoimmunity: other risk factors probably serve as disease triggers.(Genes & Cells)
Author: Tina Hesman Saey
Publication: Science News (Magazine/Journal)
Date: June 6, 2009
Publisher: Science Service, Inc.
Volume: 175Issue: 12Page: 10(1)

Distributed by Gale, a part of Cengage Learning ... Read more

Product Description
This digital document is an article from FOCUS: Journal for Respiratory Care & Sleep Medicine, published by Focus Publications, Inc. on May 1, 2010. The length of the article is 1528 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Narcolepsy, cataplexy and the reward system.(SLEEP MEDICINE)
Author: Regina Patrick
Publication: FOCUS: Journal for Respiratory Care & Sleep Medicine (Magazine/Journal)
Date: May 1, 2010
Publisher: Focus Publications, Inc.
Page: 14(2)

Distributed by Gale, a part of Cengage Learning ... Read more

Product Description
The article is excerpted fromGale Encyclopedia of Medicine.

Consultthe second edition of this authoritative, comprehensive, in-depthmedical guide for information on more than 1,700 medical topics inlanguage accessible to adult laypersons. Presented in a singlealphabetical sequence, articles range in length from one or twoparagraphs for minor topics, to several pages or more for major topics.Disease/disorder articles typically cover definition; description;causes and symptoms; diagnosis; treatments; prevention; and more.Test/treatment articles typically cover definition; purposes;precautions; preparation; risks; normal and abnormal results; and muchmore. This second edition includes more than 200 new entries, 300updated entries, approximately 650 color images and illustrations, anda comprehensive subject index. New features include biographical andhistorical sidebars throughout the text.

Disease/disorder articles contain some or all of the following sections:

• Definitions -- brief dictionary-style definition of the disorder
• Descriptions -- overview of the disorder; who gets it and why
• Causes & symptoms -- process, substance or organism thatproduces the condition; any risk factors that increase susceptibilityto the condition; signs and symptoms of the disease
• Diagnosis -- overview of procedures and tests used todiagnose the condition; how the test is done; who should be tested andwhen; time required; cost; whether it's typically covered by insurance
• Treatments -- overview of conventional methods of care ormanagement of the condition, such as drugs, surgeries, physicaltherapy, etc.
• Alternative treatments -- overview of alternative/complementary therapies that may be used to treat the condition
• Prognosis -- probable outcome of the disease
• Preventions -- what actions can be taken to prevent the condition from occurring

Test/treatment articles contain some or all of the following sections:

• Definitions -- brief dictionary-style definition of the test/treatment
• Purposes -- why and when this test/treatment is prescribed
• Precautions -- when this test/treatment should not be prescribed
• Descriptions -- overview of the test/treatment including cost,length of time required, procedures followed, whether typically coveredby insurance
• Preparation -- pre-test treatment procedures, if any
• Aftercare -- post-test treatment procedures, if any
• Risks -- any complications/side effects commonly associated with the test/treatment
• Normal results -- for tests, describes the normal values; for treatments, describes the anticipated outcomes
• Abnormal results -- defines abnormal test values

Published/Released: December 2001

Product Description

Information on many genetic disorders, and the frequent new findings on them, has been extremely difficult to come by—until now. The “Gale Encyclopedia of Genetic Disorders” addresses the need for current, hard-to-find facts on emerging discoveries. The two-volume Encyclopedia, presented in a single alphabetical sequence, provides clear, complete information on genetic disorders, including conditions, tests, procedures, treatments and therapies, in articles that are both comprehensive and easy to understand, in language accessible to laypersons. The articles are arranged in a standardized format for quick comparison and ease of use, while non-disorder topics are covered in detail with extended entries. Students will want to consult the “Gale Encyclopedia of Genetic Disorders” for useful information on a range of well known disorders, including Down Syndrome, Trisomy, Hemophilia and Tourette Syndrome, and rarely seen diseases such as Meckel Syndrome, Neuraminidase Deficiency and Phenylketonuria.

Product Description
This digital document is an article from Pediatric News, published by Thomson Gale on April 1, 2007. The length of the article is 632 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Cataplexy is key in narcolepsy diagnosis.(Clinical Rounds)
Author: Robert Finn
Publication: Pediatric News (Magazine/Journal)
Date: April 1, 2007
Publisher: Thomson Gale
Volume: 41Issue: 4Page: 54(1)

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from FOCUS: Journal for Respiratory Care & Sleep Medicine, published by Focus Publications, Inc. on January 1, 2008. The length of the article is 1555 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Pharmaceuticals used to treat narcolepsy.(SLEEP PHARMACOLOGY)
Author: Michael J. Decker
Publication: FOCUS: Journal for Respiratory Care & Sleep Medicine (Magazine/Journal)
Date: January 1, 2008
Publisher: Focus Publications, Inc.
Page: 30(2)

Distributed by Gale, a part of Cengage Learning ... Read more

Product Description

The “Gale Encyclopedia of Mental Disorders” is a comprehensive two-volume set providing detailed information on mental disorders and conditions, in an easy-to-use format. It includes entries for all 150 disorders classified in the “Diagnostic and Statistical Manual of Mental Disorders,” and also features entries for prescription, alternative and over-the-counter drugs, as well as the various therapies used to treat mental disorders.

Product Description
This book covers the differences between insomnia, sleep apnea and narcolepsy. It also addresses the "norm" of being sleep deprived in our society. Comprehensive study with questions in the back of the book. ... Read more

Product Description
Modafinil is an analeptic drug manufactured by Cephalon, and is approved by the U.S. Food and Drug Administration (FDA) for the treatment of narcolepsy, shift work sleep disorder, and excessive daytime sleepiness associated with obstructive sleep apnea. Modafinil, like other stimulants, increases the release of monoamines, specifically the catecholamines norepinephrine and dopamine, from the synaptic terminals. However, modafinil also elevates hypothalamic histamine levels, leading some researchers to consider Modafinil a "wakefulness promoting agent" rather than a classic amphetamine-like stimulant (as evidenced by the difference in c-Fos distribution caused by modafinil as compared to amphetamine). Despite modafinil's histaminergic action, it still partially shares the actions of amphetamine-class stimulants due to its effects on norepinephrine and dopamine. An NIAAA study highlighted "the need for heightened awareness for potential abuse of and dependence on modafinil in vulnerable populations" due to the drug's effect on dopamine in the brain's reward center. ... Read more

Customer Reviews (1)

GOOLGE THE PRODUCT DESCRIPTION...
Modafinil is an analeptic drug manufactured by Cephalon, and is approved by the U.S. Food and Drug Administration (FDA) for the treatment of narcolepsy, shift work sleep disorder, and excessive daytime sleepiness associated with obstructive sleep apnea. Modafinil, like other stimulants, increases the release of monoamines, specifically the catecholamines norepinephrine and dopamine, from the synaptic terminals. However, modafinil also elevates hypothalamic histamine levels, leading some researchers to consider Modafinil a "wakefulness promoting agent" rather than a classic amphetamine-like stimulant (as evidenced by the differenc

THE WHOLE BOOK IS FROM WIKIPEDIA. ... Read more

Product Description
The latest findings on the extraordinarily strong association between HLA-DR2, Dw2, DPwl and narcolepsy are here thoroughly documented. Recent observations on immunological aspects, DNA typings and 16 other genetic markers in narcolepsy are dealt with, and investigations into the molecular biological and genetic aspects of an animal dog model are described. The book also provides details of extensive clinical studies performed in Japan on several hundred patients suffering from narcolepsy and related disorders of excessive daytime somnolence. Finally, the book considers the rapidly advancing research into HLA and DNA and the potential significance of these findings to the development of DNA diagnosis of narcolepsy. ... Read more

Product Description
Rapid eye movement (sleep) - Sleep (non-human),Polysomnogram, Sleep disorder, PGO waves, Dream,Narcolepsy,Parasomnia, Lucid dream ... Read more